ARAUJO, E.B. deMURAMOTO, E.NAGAMATI, L.T.CALDEIRA FILHO, J.S.COUTO, R.M.SILVA, C.P.G.2014-11-172014-11-182015-04-022014-11-172014-11-182015-04-02ARAUJO, E.B. de; MURAMOTO, E.; NAGAMATI, L.T.; CALDEIRA FILHO, J.S.; COUTO, R.M.; SILVA, C.P.G. Comparison of sup(131)I-TYRsup(3)-octreotate and sup(131)I-DOTA-TYRsup(3)Octreotate: the egffect of DOTA on pharmacokinetics and stability. In: INTERNATIONAL SYMPOSIUM TRENDS IN RADIOPHARMACEUTICALS, 14-18 November, 2005, Vienna. <b>Proceedings...</b> p. 243-251. DisponÃvel em: http://repositorio.ipen.br/handle/123456789/15831.http://repositorio.ipen.br/handle/123456789/15831243-251openAccesschloraminesexcretionin vitroin vivoiodine 131labelled compoundsliverpeptidesradiochemistryradionuclide kineticsradiopharmaceuticalsstabilityComparison of sup(131)I-TYRsup(3)-octreotate and sup(131)I-DOTA-TYRsup(3)Octreotate: the egffect of DOTA on pharmacokinetics and stabilityTexto completo de eventohttps://orcid.org/0000-0003-0456-5589